PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
12.18%
Growth of 12.18% while CRWD shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
5.10%
Cost growth of 5.10% while CRWD maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
15.91%
Growth of 15.91% while CRWD shows flat gross profit. Bruce Berkowitz would examine quality advantage.
3.33%
Margin change of 3.33% while CRWD shows flat margins. Bruce Berkowitz would examine quality advantage.
5.87%
R&D change of 5.87% while CRWD maintains spending. Bruce Berkowitz would investigate effectiveness.
5.22%
G&A change of 5.22% while CRWD maintains overhead. Bruce Berkowitz would investigate efficiency.
9.80%
Marketing expense change of 9.80% while CRWD maintains spending. Bruce Berkowitz would investigate effectiveness.
-971.43%
Other expenses reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine efficiency.
7.63%
Operating expenses change of 7.63% while CRWD maintains costs. Bruce Berkowitz would investigate control.
6.36%
Total costs change of 6.36% while CRWD maintains costs. Bruce Berkowitz would investigate control.
-2.75%
Interest expense reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine advantage.
-7.16%
D&A reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine efficiency.
26.05%
EBITDA change of 26.05% while CRWD is flat. Bruce Berkowitz would examine quality.
-1.24%
EBITDA margin decline while CRWD shows 0.00% growth. Joel Greenblatt would examine position.
25.17%
Income change of 25.17% while CRWD is flat. Bruce Berkowitz would examine quality.
11.58%
Margin change of 11.58% while CRWD is flat. Bruce Berkowitz would examine quality.
-13.75%
Other expenses reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine advantage.
23.60%
Income change of 23.60% while CRWD is flat. Bruce Berkowitz would examine quality.
10.18%
Margin change of 10.18% while CRWD is flat. Bruce Berkowitz would examine quality.
48.48%
Tax expense change of 48.48% while CRWD maintains burden. Bruce Berkowitz would investigate strategy.
19.52%
Income change of 19.52% while CRWD is flat. Bruce Berkowitz would examine quality.
6.54%
Margin change of 6.54% while CRWD is flat. Bruce Berkowitz would examine quality.
19.79%
EPS change of 19.79% while CRWD is flat. Bruce Berkowitz would examine quality.
20.00%
Diluted EPS change of 20.00% while CRWD is flat. Bruce Berkowitz would examine quality.
-0.19%
Share count reduction while CRWD shows 0.00% change. Joel Greenblatt would examine strategy.
-0.24%
Diluted share reduction while CRWD shows 0.00% change. Joel Greenblatt would examine strategy.